← Open Payments lookup

ANGELA ANUKAM: Open Payments

NPI 1841734944 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,537 in 66 payments from 9 companies in 2025. Trend: 2023 $2,047 · 2024 $2,084 · 2025 $2,537

Food & beverage: $2,433Education: $104
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$1,040
ABBVIE INC.24$507
Teva Pharmaceuticals USA, Inc.4$255
Otsuka America Pharmaceutical, Inc.3$221
Gilead Sciences, Inc.2$154
Neurocrine BioSciences, Inc.1$129
E.R. Squibb & Sons, L.L.C.1$125
Alkermes, Inc.1$76
Vanda Pharmaceuticals Inc.2$31

Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, INGREZZA, COBENFY, ABILIFY MAINTENA, Epclusa, REXULTI.

Industry payments across NY — which companies pay providers there.